Medtronic may have to sell off units to satisfy EU Regulators in the Covidien deal

Medtronic offers EU concessions in $43 billion Covidien deal (Reuters)
U.S. medical device maker Medtronic Inc has offered concessions in a bid to secure European Union regulatory approval for its $43 billion acquisition of Irish rival Covidien Plc, the European Commission said.
The takeover will put Medtronic on about the same footing as global leader Johnson & Johnson and reduce its overall global tax burden, although it has said the takeover is not an "inversion" deal for tax reasons.
Medtronic submitted concessions last Friday, the EU antitrust authority said. The Commission, which did...